Cargando…

Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients

BACKGROUND/AIM: Right sided colon cancer (RsCC) is proposed to be a distinct disease entity to left sided colon cancer (LsCC). We seek to confirm primary tumour location as an independent prognostic factor in locoregional colorectal cancer. METHODS: All patients with stage I – III primary adenocarci...

Descripción completa

Detalles Bibliográficos
Autores principales: Brungs, Daniel, Aghmesheh, Morteza, de Souza, Paul, Ng, Weng, Chua, Wei, Carolan, Martin, Clingan, Philip, Healey, Emma, Rose, June, Tubaro, Tameika, Ranson, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385038/
https://www.ncbi.nlm.nih.gov/pubmed/28390415
http://dx.doi.org/10.1186/s12885-017-3255-z
_version_ 1782520531532120064
author Brungs, Daniel
Aghmesheh, Morteza
de Souza, Paul
Ng, Weng
Chua, Wei
Carolan, Martin
Clingan, Philip
Healey, Emma
Rose, June
Tubaro, Tameika
Ranson, Marie
author_facet Brungs, Daniel
Aghmesheh, Morteza
de Souza, Paul
Ng, Weng
Chua, Wei
Carolan, Martin
Clingan, Philip
Healey, Emma
Rose, June
Tubaro, Tameika
Ranson, Marie
author_sort Brungs, Daniel
collection PubMed
description BACKGROUND/AIM: Right sided colon cancer (RsCC) is proposed to be a distinct disease entity to left sided colon cancer (LsCC). We seek to confirm primary tumour location as an independent prognostic factor in locoregional colorectal cancer. METHODS: All patients with stage I – III primary adenocarcinoma of colon were identified from the New South Wales (NSW) clinical cancer registry (2006–2013). Primary tumour location (RsCC vs LsCC) survival analyses were conducted using the Kaplan-Meier method, and adjusted hazard ratios for 5-year all-cause mortality (OS) and 5-year cancer specific mortality (CSS) were obtained using Cox proportional hazards regression. RESULTS: We identified 9509 patients including 5051 patients with RsCC and 4458 with LsCC. Patients with RsCC were more likely to be older, female, have a higher Charlson comorbidity index, and have worse tumour prognostic factors. In univariate analysis of all stages combined, those patients with RsCC had a worse overall survival (OS, HR 1.20 95% CI 1.11–1.29, p < 0.0001), although this was not significant in the multivariate analysis (HR 0.96 95% CI 0.89–1.04, p = 0.35). Stage I patients with RsCC had a trend to improved OS (multivariate HR 0.84 95% CI 0.69–1.01, p = 0.07) and a significantly improved CSS (multivariate HR 0.51 95% CI 0.35–0.75, p = 0.0006). In stage II patients with RsCC there was a significantly improved OS (multivariate HR 0.85 95% CI 0.75–0.98, p = 0.02) and CSS (multivariate HR 0.59 95% CI 0.45–0.78, p = 0.0002) compared to LsCC. In stage III patients, those with RsCC had a worse OS (multivariate HR 1.13 95% CI 1.01–1.26, p = 0.032) and a trend to worse CSS (multivariate HR 1.12 95% CI 0.94–1.33, p = 0.22). CONCLUSIONS: Primary tumour location is an important prognostic factor in locoregional colon cancer with an effect that varies by stage. RsCC is associated with lower all-cause mortality in stage II, and higher all-cause mortality in stage III. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3255-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5385038
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53850382017-04-12 Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients Brungs, Daniel Aghmesheh, Morteza de Souza, Paul Ng, Weng Chua, Wei Carolan, Martin Clingan, Philip Healey, Emma Rose, June Tubaro, Tameika Ranson, Marie BMC Cancer Research Article BACKGROUND/AIM: Right sided colon cancer (RsCC) is proposed to be a distinct disease entity to left sided colon cancer (LsCC). We seek to confirm primary tumour location as an independent prognostic factor in locoregional colorectal cancer. METHODS: All patients with stage I – III primary adenocarcinoma of colon were identified from the New South Wales (NSW) clinical cancer registry (2006–2013). Primary tumour location (RsCC vs LsCC) survival analyses were conducted using the Kaplan-Meier method, and adjusted hazard ratios for 5-year all-cause mortality (OS) and 5-year cancer specific mortality (CSS) were obtained using Cox proportional hazards regression. RESULTS: We identified 9509 patients including 5051 patients with RsCC and 4458 with LsCC. Patients with RsCC were more likely to be older, female, have a higher Charlson comorbidity index, and have worse tumour prognostic factors. In univariate analysis of all stages combined, those patients with RsCC had a worse overall survival (OS, HR 1.20 95% CI 1.11–1.29, p < 0.0001), although this was not significant in the multivariate analysis (HR 0.96 95% CI 0.89–1.04, p = 0.35). Stage I patients with RsCC had a trend to improved OS (multivariate HR 0.84 95% CI 0.69–1.01, p = 0.07) and a significantly improved CSS (multivariate HR 0.51 95% CI 0.35–0.75, p = 0.0006). In stage II patients with RsCC there was a significantly improved OS (multivariate HR 0.85 95% CI 0.75–0.98, p = 0.02) and CSS (multivariate HR 0.59 95% CI 0.45–0.78, p = 0.0002) compared to LsCC. In stage III patients, those with RsCC had a worse OS (multivariate HR 1.13 95% CI 1.01–1.26, p = 0.032) and a trend to worse CSS (multivariate HR 1.12 95% CI 0.94–1.33, p = 0.22). CONCLUSIONS: Primary tumour location is an important prognostic factor in locoregional colon cancer with an effect that varies by stage. RsCC is associated with lower all-cause mortality in stage II, and higher all-cause mortality in stage III. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3255-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-04-08 /pmc/articles/PMC5385038/ /pubmed/28390415 http://dx.doi.org/10.1186/s12885-017-3255-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Brungs, Daniel
Aghmesheh, Morteza
de Souza, Paul
Ng, Weng
Chua, Wei
Carolan, Martin
Clingan, Philip
Healey, Emma
Rose, June
Tubaro, Tameika
Ranson, Marie
Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients
title Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients
title_full Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients
title_fullStr Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients
title_full_unstemmed Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients
title_short Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients
title_sort sidedness is prognostic in locoregional colon cancer: an analysis of 9509 australian patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385038/
https://www.ncbi.nlm.nih.gov/pubmed/28390415
http://dx.doi.org/10.1186/s12885-017-3255-z
work_keys_str_mv AT brungsdaniel sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients
AT aghmeshehmorteza sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients
AT desouzapaul sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients
AT ngweng sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients
AT chuawei sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients
AT carolanmartin sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients
AT clinganphilip sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients
AT healeyemma sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients
AT rosejune sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients
AT tubarotameika sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients
AT ransonmarie sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients